↓ Skip to main content

Cochrane Database of Systematic Reviews

Corticosteroids for the long-term treatment in multiple sclerosis

Overview of attention for article published in Cochrane database of systematic reviews, January 2008
Altmetric Badge

About this Attention Score

  • Good Attention Score compared to outputs of the same age (73rd percentile)
  • Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter
1 tweeter
wikipedia
2 Wikipedia pages

Citations

dimensions_citation
54 Dimensions

Readers on

mendeley
131 Mendeley
Title
Corticosteroids for the long-term treatment in multiple sclerosis
Published in
Cochrane database of systematic reviews, January 2008
DOI 10.1002/14651858.cd006264.pub2
Pubmed ID
Authors

Alfonso Ciccone, Sandro Beretta, Fabio Brusaferri, Ian Galea, Alessandra Protti, Chiara Spreafico

Abstract

Short term high dose corticosteroid treatment improves symptoms and short term disability after an acute exacerbation of multiple sclerosis (MS) but it is unknown whether its long-term use can reduce the accumulation of disability.

Twitter Demographics

The data shown below were collected from the profile of 1 tweeter who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 131 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Spain 1 <1%
United States 1 <1%
Unknown 129 98%

Demographic breakdown

Readers by professional status Count As %
Student > Master 19 15%
Student > Bachelor 18 14%
Researcher 15 11%
Student > Ph. D. Student 12 9%
Student > Doctoral Student 12 9%
Other 32 24%
Unknown 23 18%
Readers by discipline Count As %
Medicine and Dentistry 63 48%
Nursing and Health Professions 9 7%
Agricultural and Biological Sciences 8 6%
Neuroscience 8 6%
Psychology 5 4%
Other 13 10%
Unknown 25 19%

Attention Score in Context

This research output has an Altmetric Attention Score of 4. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 30 September 2022.
All research outputs
#6,281,826
of 22,365,276 outputs
Outputs from Cochrane database of systematic reviews
#8,137
of 12,237 outputs
Outputs of similar age
#35,608
of 152,563 outputs
Outputs of similar age from Cochrane database of systematic reviews
#58
of 95 outputs
Altmetric has tracked 22,365,276 research outputs across all sources so far. This one has received more attention than most of these and is in the 70th percentile.
So far Altmetric has tracked 12,237 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 30.1. This one is in the 32nd percentile – i.e., 32% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 152,563 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 73% of its contemporaries.
We're also able to compare this research output to 95 others from the same source and published within six weeks on either side of this one. This one is in the 35th percentile – i.e., 35% of its contemporaries scored the same or lower than it.